{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:25:28Z","timestamp":1787891128149,"version":"build-2784847793"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,15]]},"DOI":"10.1093\/infdis\/jix415","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T11:10:02Z","timestamp":1503486602000},"page":"966-968","source":"Crossref","is-referenced-by-count":11,"title":["Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16\/18 Vaccination"],"prefix":"10.1093","volume":"216","author":[{"given":"Tuomas","family":"Lehtinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"S\u00f6derlund-Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Pet\u00e4j\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari","family":"Jokiranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Natunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"key\n\t\t\t\t20171115102735_CIT0001","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","article-title":"The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States","volume":"17","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20171115102735_CIT0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents","volume":"203","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171115102735_CIT0003","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/LGT.0b013e318203ae61","article-title":"HPV in men: an update","volume":"15","year":"2011","journal-title":"J Low Genit Tract Dis"},{"key":"key\n\t\t\t\t20171115102735_CIT0004","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017\u2014recommendations","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171115102735_CIT0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jadohealth.2008.10.002","article-title":"Immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years","volume":"44","year":"2009","journal-title":"J Adolesc Health"},{"key":"key\n\t\t\t\t20171115102735_CIT0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171115102735_CIT0007","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/infdis\/jit360","article-title":"Efficacy of the HPV-16\/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation","volume":"208","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171115102735_CIT0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of the HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-if study analysis of the randomized, double-blind PATRICIA trial","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20171115102735_CIT0009","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.vaccine.2014.12.019","article-title":"Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171115102735_CIT0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JCM.02007-08","article-title":"Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus","volume":"47","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171115102735_CIT0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1258\/095646206776253453","article-title":"Population based enrolment of adolescent girls into long-term human papillomavirus vaccination trial","volume":"17","year":"2006","journal-title":"Int J STD & AIDS"},{"key":"key\n\t\t\t\t20171115102735_CIT0012","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","year":"2014","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20171115102735_CIT0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2004.11.011","article-title":"Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina","volume":"124","year":"2005","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20171115102735_CIT0014","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/1055-9965.EPI-08-0467","article-title":"Correlates of human papillomavirus viral load with infection site in asymptomatic men","volume":"17","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key\n\t\t\t\t20171115102735_CIT0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1086\/596050","article-title":"Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study","volume":"199","year":"2009","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/8\/966\/21784653\/jix415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T15:28:17Z","timestamp":1510759697000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/8\/966\/4093091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,24]]},"published-print":{"date-parts":[[2017,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix415","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,15]]},"published":{"date-parts":[[2017,8,24]]}}}